2011
DOI: 10.1002/minf.201100049
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of Structure Based Virtual Screening Protocols Against Thymidine Monophosphate Kinase Inhibitors as Antitubercular Agents

Abstract: Thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKMtub ) is an established drug target against tuberculosis. The enzyme TMPKMtub is responsible for the survival of bacterium MTB and required to synthesize an essential building block of the bacterial DNA which is thymidine triphosphate (TTP). There are several potent inhibitors available against the target enzyme but the majority are substrate analogues. Recently, three dimensional structures of the enzyme TMPKMtub inhibitor complexes were res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…The prime objective behind using the decoy data set is to avoid the artificial enrichment . The decoys were prepared according to the protocol established earlier …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The prime objective behind using the decoy data set is to avoid the artificial enrichment . The decoys were prepared according to the protocol established earlier …”
Section: Methodsmentioning
confidence: 99%
“…37 The decoys were prepared according to the protocol established earlier. 38 For VS, Maybridge Screening Collection was downloaded from the Maybridge website (https://www.maybridge.com). As of December, 2018, Maybridge screening collection consisted of 52 066 compounds.…”
Section: ■ Conclusionmentioning
confidence: 99%
“…Amidst several studies focusing on SAR studies Zaheer Ul Haq and his team optimized a structure based virtual screening protocol for TMPkmt inhibitors (56). To test the protocol they used a collection of 10,000 randomly selected molecules from the National Cancer Institute database along with 105 known substrates and inhibitors of TMPKmt.…”
Section: Computer Aided Drug Designmentioning
confidence: 99%